维普期刊资源整合服务平台（V6.5）

96篇 您的检索式：作者名="BALDWIN DS"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Clinical experience with paroxetine in socal anxiety disorder显示文摘	Baldwin Ds	2000	Int Clin Psychopharmacal2000，15，：	1
2	Pharmacological treatment of general- ized anxiety disorder显示文摘	Baldwin DS Ajel KI Garner M	2010	Curr Top Behav Neurosci2010，12，16：	1
3	Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression显示文摘	Basseres DS Baldwin AS	2006	Oncogene2006，25，51：	1
4	Pharmacotherapy of generalized anxiety disorder显示文摘	Allgulander C Baldwin DS	2013	Mod Trends Pharmaeopsychiatri2013，29，：	1
5	Superiority of escitalopram to paroxetine in the treatment of depression 显示文摘	Kasper S Baldwin DS Larsson LS	2009	Eur Neuro Psychopharmacol2009，19，4：	1
6	Evidence -based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharma- cology 显示文摘	Baldwin DS Anderson IM Nutt DJ	2005	J Psychopharmacol2005，19，6：	1
7	Vortioxetine ( Lu AA21004) in the long- term open- label treatment of major depressive disorder 显示文摘	Baldwin DS Hansen T Florea I	2012	Current Medical Re- seach & Opinion2012，28，10：	1
8	Eseitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised,placebo-controlled, double-blind study显示文摘	Baldwin DS Huusom AK Maehlum E	2006	Br J Psychiatry2006，189，3：	1
9	Evidence-based pharmacotherapy of generalized anxiety disorder显示文摘	Baldwin DS Polkinghorn C	2005	Int J Neuropsychopharma- col2005，8，：	1
10	Intrarenal vascular sclerosis in IgA nephropathy显示文摘	Feiner HD Cabili S Baldwin DS	1982	Clin Nephrol1982，18，4：	1
11	A double - blind, randomized, parallel - group, flexible study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder显示文摘	Baldwin DS Cooper JA Huuson AK	2006	Int Clin Psychophamarcol2006，21，：	1
12	Escitalopram:efficancy and tolerabitity in the treatment of depression显示文摘	Baldwin DS	2002	Hosp Med2002，63，11：	1
13	Pregabalin for the treatment of generalized anxiety disorder: an update 显示文摘	Baldwin DS Ajel K Masdrakis VG	2013	Neuropsychiatr Dis Treat2013，9，：	1
14	Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression显示文摘	Basseres DS Baldwin AS	2006	Oncogene2006，25，51：	1
15	The McMaster family assessment device显示文摘	Epstein NB Baldwin LM Biahop DS	1983	J Marital and Family Therapy1983，9，：	1
16	Clinical experience with paroxetine in socialanxietydisorder显示文摘	Baldwin DS		0，，1：	1
17	Nuclear factor-kappaB and inhibitor of kap- paB kinase pathways in oncogenic initiation and progression 显示文摘	Basseres DS Baldwin AS	2006	On- cogene2006，25，51：	1
18	Case - control study of 234 recently discharged psychiatric patient suicides 显示文摘	King EA Baldwin DS Sinclair JM The Wessex Recent In - Patient Suicide Study 1	2001	Br J Psychiatry2001，178，：	1
19	Antidepressants mad their effect on sleep 显示文摘	Mayers AG Baldwin DS	2005	Hum Psychopharmacol2005，20，8：	1
20	Clinical experience with paroxitine in social anxiety disorder显示文摘	Baldwin DS	2000	Int Paychopharmacal2000，15，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示